SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-24-002047
Filing Date
2024-04-01
Accepted
2024-04-01 21:36:09
Documents
1
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 5  
1 ownership.xml 5 13704
  Complete submission text file 0001683168-24-002047.txt   15830
Mailing Address 3031 TISCH WAY SUITE 505 SAN JOSE CA 95128
Business Address
Pearson Mark E. (Reporting) CIK: 0001486558 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-39114 | Film No.: 24812017

Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3031 TISCH WAY SUITE 505 SAN JOSE CA 95128
Business Address 3031 TISCH WAY SUITE 505 SAN JOSE CA 95128 (408) 479-7842
Altamont Pharmaceutical Holdings, LLC (Reporting) CIK: 0001745878 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 5 | Act: 34 | File No.: 001-39114 | Film No.: 24812018